ScholarWorks@Korea University College of Medicine

Current filters:
Current filters:
Current filters:
Current filters:
Add filters:

Results 1-1 of 1 (Search time: 0.006 seconds).

SCIESCOPUS
Phase I/II study of first-line combination therapy with sorafenib plus resminostat, an oral HDAC inhibitor, versus sorafenib monotherapy for advanced hepatocellular carcinoma in east Asian patients

Tak, Won Young, Ryoo, Baek-Yeol, Lim, Ho Yeong, Kim, Do-Young, Okusaka, Takuji, Ikeda, Masafumi, Hidaka, Hisashi, Yeon, Jong-Eun, Mizukoshi, Eishiro, Morimoto, Manabu, et al.

ArticleIssue Date2018CitationInvestigational New Drugs, v.36, no.6, pp.1072 - 1084PublisherKluwer Academic Publishers
1

Discover

Type

Language

STATISTICS
Total View :7,752,987
Today View :1,596

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841) 82-2-2286-1265

COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어